Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Post-operative depletion of platelet count is associated with anastomotic insufficiency following intrahepatic cholangiojejunostomy: a case–control study from the results of 220 cases of intrahepatic cholangiojejunostomy

  • Takehiro Noji1Email author,
  • Takahiro Tsuchikawa1,
  • Yuma Ebihara1,
  • Toru Nakamura1,
  • Kentaro Kato1,
  • Joe Matsumoto1,
  • Eiichi Tanaka1,
  • Toshiaki Shichinohe1 and
  • Satoshi Hirano1
BMC Surgery201414:81

https://doi.org/10.1186/1471-2482-14-81

Received: 12 July 2013

Accepted: 7 October 2014

Published: 16 October 2014

Abstract

Background

Post-operative anastomotic insufficiency following major hepato-biliary surgery has significant impacts on the post-operative course. Recent reports have revealed that platelets play an important role in liver regeneration and wound healing. From these experimental and clinical results on platelet function, we hypothesized that post-operative platelet depletion (to <10 × 104/μL) would be associated with delayed liver regeneration as well as anastomotic insufficiency of intrahepatic cholangiojejunostomy. However, little information is available regarding correlations between platelet count and these complications. The purposes of the present study were, firstly, to evaluate the incidence of anastomotic insufficiency following intrahepatic cholangiojejunostomy and, secondly, to evaluate whether platelet depletion represents a risk factor for anastomotic insufficiency in intrahepatic cholangiojejunostomy.

Methods

Participants in this study comprised 220 consecutive patients who underwent intrahepatic cholangiojejunostomy following hepato-biliary resection for biliary malignancies between September 1998 and December 2010. Anastomotic insufficiency was confirmed by cholangiographic demonstration of leakage from the anastomosis using contrast medium introduced via a biliary drainage tube or prophylactic drain placed during surgery.

Results

Anastomotic insufficiency of the intrahepatic cholangiojejunostomy occurred in 13 of 220 patients (6%). Thirteen of the 220 patients, including one with anastomotic insufficiency, died during the study. Uni- and multivariate analyses both revealed that platelet depletion on post-operative day 1 (<10 × 104/μL) correlated with anastomotic insufficiency.

Conclusion

Post-operative platelet depletion was closely associated with anastomotic insufficiency following intrahepatic cholangiojejunostomy. This correlation has been established, but the underlying mechanisms have not.

Keywords

Biliary reconstructionIntrahepatic cholangiojejunostomyPlatelet depletionLiver regeneration

Background

Liver resection with intrahepatic cholangiojejunostomy for biliary malignancies is one of the most demanding surgeries and is associated with a high morbidity rate. Recent reports have revealed post-operative morbidity rates ranging from 42% to 59% [16]. Morbidity is high because the operations comprise various difficult and highly technical procedures. We have previously reported that the most frequent post-operative complications are organ/space surgical-site infection (SSI), liver failure, respiratory complications, and anastomotic insufficiency of the intrahepatic cholangiojejunostomy [7].

In general, intrahepatic cholangiojejunostomy is thought to be more technically demanding than hepaticojejunostomy. Previous reports have therefore shown that the incidence of anastomotic insufficiency after intrahepatic cholangiojejunostomy (6.8-50%) is higher than that after hepaticojejunostomy (0.4-8%) [4, 812]. Several studies have reported on bile leakage after intrahepatic cholangiojejunostomy, but those did not clearly specify whether the bile leak arose from the liver stump or from the site of anastomosis for the hepaticojejunostomy, as Nagino et al. suggested in their previous report [9]. Precise determination of the incidence of, and risk factors for, anastomotic insufficiency after intrahepatic cholangiojejunostomy remains difficult.

Recent experimental studies have suggested that blood platelets play a pivotal role in liver regeneration after partial liver resection [1316]. A depleted platelet count severely suppresses liver regeneration, whereas induction of thrombocytosis by administration of thrombopoietin or splenectomy has been shown to accelerate liver regeneration [1416]. Some evidence also suggests that platelet-derived serotonin plays an essential role in platelet-mediated liver regeneration [16]. In addition, several clinical studies have revealed that platelet counts below 10 × 104/μL pre-operatively and immediately post-operatively are associated with an increased risk of mortality and delayed recovery of liver function after partial liver resection [1719]. Experimental evidence has also shown that bile duct cells regenerate along with other hepatocytes [20]. Other recent experimental studies have concluded that platelets play important roles in not only liver regeneration, but also tissue repair [21, 22]. Given these results regarding platelet functions, we hypothesized that post-operative platelet depletion (to <10 × 104/μL) would be associated with delayed liver regeneration and anastomotic insufficiency after intrahepatic cholangiojejunostomy. However, data for this hypothesis are lacking. The purpose of this study was therefore to evaluate whether post-operative depletion of platelets was associated with anastomotic insufficiency following intrahepatic cholangiojejunostomy. The primary outcome parameter was incidence of anastomotic insufficiency with intrahepatic cholangiojejunostomy. We performed uni- and multivariate analyses to identify both clinical variables associated with anastomotic insufficiency and clinical factors correlated with platelet depletion in the post-operative period.

Methods

Study participants

Participants comprised 220 consecutive patients who underwent intrahepatic cholangiojejunostomy following hepato-biliary resection for biliary malignancies from September 1998 and December 2010.

Pre-operative biliary drainage

All hepatectomies were performed after the total bilirubin concentration had decreased to below 2 mg/dL. Pre-operative biliary decompression was performed to reduce serum bilirubin concentration to below 2 mg/dL for all patients with jaundice, and to control segmental cholangitis.

Pre-operative portal vein embolization (PE)

Pre-operative PE of the liver was performed when right trisegmentectomy, right hepatectomy, or left trisegmentectomy was planned. Indications and procedures for PE have been described previously [23].

Surgery

Hepatectomies were classified according to the Brisbane 2000 Terminology [24]. Hepatoduodenal ligament skeletonization, lymphadenectomy, and various hepatectomies with en bloc resection of the caudate lobe and extrahepatic bile duct were performed. Details of these procedures have been described previously [7].

Our procedure for bilioenteric anastomosis using the Roux-en-Y jejunal limb has been described previously with video [25]. Briefly, the jejunal limb was brought to the hepatic ducts via the standard retrocolic-anteduodenal route. In the case of hepatic pancreatoduodenectomy, reconstruction was performed according to Child’s method with an end-to-side pancreaticojejunostomy. All cholangiojejunostomies were performed by anastomosing the mucosal layers of the bile duct and intestine. Transanastomotic stents were placed in all patients, usually introduced via a trans-jejunal route or occasionally a transhepatic route. Although most bile ducts to be anastomosed were drained by percutaneous transhepatic biliary drainage, a trans-jejunal route rather than a transhepatic route was preferred because the sinus tract between the liver and abdominal wall was usually broken at laparotomy.

Drains were placed prophylactically near the anastomosis and the cut surface of the liver. Until the end of 2004, Penrose drains were used along the hepatic stump. From 2005, 10-mm capillary silicone drains were placed in the same spaces.

Definitions of post-operative complications

Post-operative complications were graded according to the Clavien-Dindo classification [26]. Anastomotic insufficiency of intrahepatic cholangiojejunostomy was identified by cholangiographic demonstration of leakage from the anastomosis using contrast medium introduced via a biliary drainage tube or prophylactic drain placed during surgery [9]. This procedure allowed us to differentiate between an anastomotic leak and bile leaking from the liver stump.

Organ/space SSI was defined as follows: with intra-abdominal collections; drain/s left in place for more than 3 weeks; patients with severe complications such as sepsis requiring admission to the intensive care unit; hemorrhage needing interventional radiology; or repeat laparotomy. In this group, pancreatic- or bile-related infectious complications were also included. Patients with organ/space SSI did not include those with anastomotic insufficiency. Post-operative liver failure was defined as International Study Group of Liver Surgery (ISGLS) liver failure grade B/C [27].

Statistical analysis

Statistical analyses were performed using the Mann–Whitney U test, a χ2 test, or Fisher’s exact test and the Kruskal-Wallis test. Values of p <0.05 were considered statistically significant. All variables reaching a p- value of less than 0.1 in univariate analysis were included in a multivariate analysis using a logistic step-by-step regression model. Results are presented as odds ratios (ORs) with 95% confidence intervals (CIs).

Informed consent

The need to obtain informed consent for participation in this retrospective study was waived by the institutional review board.

Statements

We confirm that all study protocols were approved by ethics committee of Hokkaido University Hospital.

Results

A total of 220 patients (146 men, 74 women) were enrolled, comprising 140 with extra-hepatic bile duct cancer, 45 with intrahepatic cholangiocarcinoma, and 35 with gallbladder carcinoma. Median age was 68 years (range, 41–81 years).

Pre- and post-operative patient characteristics are presented in Table 1. Median operation time was 647 min (range, 415–1180 min) and median estimated blood loss was 1783 mL (range, 510–24,520 mL). The median number of reconstructed bile ducts was 3 (range, 1–5).
Table 1

Subject characteristics

Subject characteristics

Number of subjects

Age (years) median: 68

>68

126

Sex

Male/Female

146/74

Preoperative diagnosis

BDC

140

 

GBC

35

 

ICC

45

Body mass index; median: 22

<22

105

Diabetes mellitus

Positive

39

ICGR15 > 10%

Yes

129

ICGR15 > 15%

Yes

37

Preoperative biliary drainage

ENBD/PTBD

64/111

Preoperative albumin (g/dL); median: 3.8

<3.9

112

Preoperative portal vein embolism

Yes

114

Type of hepatectomy

Right

118

 

Left

79

 

Trisegmentectomy: Right/Left

10/11

 

Other

2

Operative blood loss (mL); median: 1783

>1700

108

Operation time (min); median: 647

>660

154

Pancreaticoduodenectomy

Yes

30

Vascular combined resection

Hepatic artery

24

 

Portal vein

118

Number of bile duct reconstructions; median: 3

≥3

139

Blood transfusion

Yes

84

Post-operative max AST (IU); median: 443

>440

110

Post-operative max ALT (IU); median: 372

>370

110

Platelet count (pre-operative period)

<12 × 104/μL

6

Platelet count (post-operative day 1)

<10 × 104/μL

30

BDC: extrahepatic cholangiocarcinoma, GBC: gallbladder cancer, ICC: intrahepatic cholangiocarcinoma, ICGR15: indocyanine green retention rate at 15 min, ENBD: endoscopic nasobiliary drainage, PTBD: percutaneous transhepatic biliary drainage, Right: right extended hepatectomy, Left: left extended hepatectomy, max: maximum, AST: aspartate aminotransferase, ALT: alanine aminotransferase.

Anastomotic insufficiency of the intrahepatic cholangiojejunostomy occurred in 13 (6%) of the 220 patients. Other post-operative complications are shown in Table 2. All instances of anastomotic leakage were treated conservatively, by maintenance of a drain that had been placed prophylactically near the cholangiojejunostomy during surgery. One patient died due to post-operative liver failure following anastomotic insufficiency.
Table 2

Postoperative complications

Postoperative complication

Number of subjects

Clavien-Dindo classification IIIa

74

IIIb

5

IVa

8

IVb

0

V

13

Liver failure

28

Anastomotic insufficiency of intrahepatic cholangiojejunostomy

13

Organ/space surgical-site infection

72

Vascular thrombosis

7

Liver abscess

7

Respiratory complications

2

Postoperative bleeding

15

Next, we investigated whether platelet depletion (to <10 × 104/μL on post-operative day (POD)1) was associated with anastomotic insufficiency. According to univariate analysis, platelet depletion was associated with anastomotic insufficiency (p < 0.01), but post-operative liver failure was not. Multivariate analyses revealed that platelet count <10 × 104/μL on POD1 was a significant predictor of anastomotic insufficiency. Vascular combined resection (portal vein and/or hepatic artery) was not associated with anastomotic insufficiency (Table 3).
Table 3

Possible risk factors for anastomotic insufficiency following intrahepatic cholangiojejunostomy

   

Univariate analysis

Multivariate analysis

Subject characteristics

 

Anastomotic insufficiency (n =13)

P

Odds ratio

95% CI

P

Age (years)

68 > (n =102)

7

1

   

Sex

Male (n =146)

9

1

   
 

Female (n =74)

4

    

BMI

<22 (n =109)

3

0.083

  

NS

 

>25 (n =33)

1

0.697

   

Diabetes mellitus

Positive (n =39)

2

1

   

ICGR15 (%); median: 10

>10 (n =129)

8

1

   

>15 (n =38)

3

0.475

   

Preoperative biliary drainage

ENBD (n =110)

4

0.262

   

PTBD (n =64)

6

    

None (n =46)

3

    

Preoperative portal vein embolism

Yes (n = 114)

5

0.396

   

Preoperative PT-INR; median: 1.1

>1.1 (n =75)

4

1

   

Preoperative albumin (mg/dL)

<3.9 (n = 112)

7

1

   

Type of hepatectomy

Left lobectomy (n =79)

6

0.389

   
 

Right lobectomy/trisegmentectomy (n =139)

7

    
 

Other (n =2)

0

    

PD

Yes (n =30)

0

0.224

   

Operative blood loss (mL)

>1700 (n =108)

7

0.781

   
 

>3000 (n =34)

3

0.429

   
 

>5000 (n =13)

2

0.174

   

Operation time (min)

>660 (n =103)

6

1

   

Vascular combined resection

Hepatic artery (n =24)

2

0.639

   

PV (n =118)

7

1

   

Number of bile duct reconstructions

≥3 (n =139)

9

0.772

   

Postoperative max AST (IU)

>440 (n =110)

9

0.251

   

Postoperative max ALT (IU)

>370 (n =110)

8

0.569

   

Platelet count (POD1)

<10 x 104/μL (n =30)

5

0.020

3.63

1.15-13.01

0.029

PT-INR (POD1); median: 1.8

>1.8 (n =105)

5

0.769

   

APTT (POD1); median: 40

>40 (n =107)

6

1

   

Postoperative liver failure

Yes (n =28)

3

0.198

   

BMI: body mass index, DM: diabetes mellitus, ENBD: endoscopic nasobiliary drainage, PTBD: percutaneous transhepatic biliary drainage, PT-INR: prothrombin time-international normalized ratio, PV: portal vein, ICGR: indocyanine green retention rate at 15 min, PD: pancreaticoduodenectomy, AST: aspartate amino transferase, ALT: alanine aminotransferase, POD: postoperative day, N.S: no statistically significant difference.

Finally, we examined clinical factors correlated with platelet count <10 × 104/μL on POD1. According to univariate analysis, platelet counts <10 × 104/μL on POD1 were closely associated with pre-operative platelet count <12 × 104/μL (below the institutional lower limit of normal), operative blood loss >1700 mL, activated partial thromboplastin time (APTT) on POD1 > 40 s, and post-operative organ/space SSI. Among these clinical factors, pre-operative platelet count, operative blood loss, and APTT on POD1 were significant independent predictors of platelet count <10 × 104/μL on POD1 in multivariate analysis (Table 4).
Table 4

Correlation between platelet depletion on POD1 and clinical characteristics

Subject characteristics

Univariate analysis

Multivariate analysis

  

Platelet count

P

Odds ratio

95% CI

P

  

(POD 1)

    
  

<10 × 104/μL

    
  

N =30

    

Age (years)

>68

19

0.553

   

BMI

<22

10

0.116

   

Diabetes mellitus

Yes

8

0.197

   

ICGR-15

>10%

21

0.231

   
 

>15%

7

0.430

   

Pre-operative albumin (mg/dL)

<3.9

16

0.845

   

Pre-operative platelet count

<12 × 104/μL

5

<0.01

34.7

3.16-380.2

<0.01

Preoperative Portal vein embolism

Yes

20

0.716

   

Type of hepatectomy

Right/trisegmen-tectomy

21

0.542

   

PD

Yes

3

0.775

   

Operative blood loss (mL)

>1700

24

<0.01

5.24

1.69-16.2

<0.01

Operation time (min)

>660

21

1

   

Concomitant resection

Hepatic artery

5

0.339

   

PV

12

0.432

   

Number of bile duct reconstructions

>3

14

0.065

-

-

N.S

Postoperative AST (IU)

>370

15

1

   

Postoperative ALT (IU)

>440

16

0.844

   

PT-INR (POD1)

>1.8

18

0.171

   

APTT (POD1)

>40

26

<0.01

5.31

1.71-16.46

<0.01

Organ/space SSI (n =30)

Yes

9

<0.01

-

-

N.S

POD1: post-operative day 1, BMI: body mass index, ICGR-15: indocyanine green retention rate at 15 min), PV: portal vein, Right: right extended hepatectomy, PD: pancreaticoduodenectomy, AST: aspartate amino transferase, ALT: alanine aminotransferase, PT-INR: prothrombin time-international normalized ratio, APTT: activated partial thromboplastin time, SSI: surgical-site infection, N.S: no statistically significant difference.

We verified that patients with pre-operative platelet depletion did not show any significant differences in pre-operative liver functions (prothrombin time-international normalized ratio (PT-INR) or indocyanine green retention rate at 15 min (ICGR-15)). No patients with severe sepsis and platelet depletion underwent hepatectomy.

Discussion

This study found a 6% incidence of anastomotic insufficiency following intrahepatic cholangiojejunostomy and also revealed that post-operative platelet depletion (to <10 × 104/μL on POD1) might be associated with increased risk of anastomotic insufficiency.

The incidence of anastomotic insufficiency following intrahepatic cholangiojejunostomy is thought to be higher than that with hepaticojejunostomy. Nagino et al. proposed that this was because the bile duct is small and fragile, and multiple anastomoses are often necessary. However, their surgical results for intrahepatic cholangiojejunostomy were suitable, with an anastomotic insufficiency rate of 6.4% (3.6% in the later period with increased experience) [9]. Our operative results with intrahepatic cholangiojejunostomy (anastomotic insufficiency rate, 6%) also appear suitable. Furthermore, Nagino et al. suggested that intra-operative massive hemorrhage or patient age were more closely associated with anastomotic insufficiency than the number of bile ducts reconstructed [9].

The present study identified a different risk factor for anastomotic insufficiency: post-operative platelet depletion. Our data showed operative blood loss >1700 mL was associated with post-operative platelet depletion on univariate analysis (Table 4). Previous results from Nagino et al. that intra-operative massive hemorrhage was associated with anastomotic insufficiency might thus be explained by post-operative platelet depletion [9].

A potentially important determinant of anastomotic insufficiency due to poor wound healing is blood supply, which for the bile ducts are accomplished mainly by the arterial system. We hypothesize that concomitant hepatic artery resection and reconstruction might have been associated with anastomotic insufficiency of intrahepatic cholangiojejunostomy, because these cases had risk factors for thrombosis. Our series included no cases with hepatic artery obstruction in the post-operative period, and our data showed no correlation with hepatic artery combined resection or anastomotic insufficiency (Table 4).

Recent clinical studies have revealed that platelet depletion in the pre- and post-operative periods is associated with delayed liver regeneration [17], and the present data support this.

Alkozai et al. noted that patients with a low immediate post-operative platelet count (<10 × 104/μL) displayed worse post-operative liver function. A low platelet count immediately post-operatively was identified as an independent risk factor for delayed post-operative recovery of liver function [17]. Liver regeneration means not only regeneration of hepatocytes, but also endothelial cells, Kupffer cells, and bile duct cells. Indeed, experimental evidence has suggested that bile duct cells regenerate along with other hepatocytes [20]. Post-operative platelet count may thus be directly related to recovery at the anastomotic site after intrahepatic cholangiojejunostomy.

The mechanism by which platelets participate in liver regeneration may work as follows: contact between platelets and hepatocytes initiates signal transduction involved in growth factor activation. Hepatocyte growth factor (HGF), vascular endothelial growth factor (VEGF), and insulin-like growth factor-1 were also found to contribute to hepatocyte proliferation [2].

Other recent experimental studies have concluded that platelets play an important role in not only liver regeneration, but also tissue repair mechanisms [21, 22]. At least 60 different biologically active substances in platelets are involved in tissue-repair mechanisms such as chemotaxis, cell proliferation and differentiation, angiogenesis, intracellular matrix deposition, immune modulation, antimicro-bial activity, and remodeling. Among these, growth factors (epidermal growth factor, platelet-derived growth factor, transforming growth factor alpha, and transforming growth factor beta) are thought to be the most important [22]. Platelet-rich plasma (PRP) has long been used as a source of platelet-related growth factors [21, 22]. Several studies using animal models have shown that PRP exerts positive effects on inflammation, remodeling, and increased vascularity after intestinal or bronchial anastomosis [28, 29].

The above experimental evidence, along with clinical data (including the present findings), supports the hypothesis that post-operative platelet depletion is closely associated with anastomotic insufficiency following intrahepatic cholangiojejunostomy. Various mechanisms have been thought to be associated with post-operative platelet depletion. Post-operative platelet depletion was commonly attributed to severe systemic infection with disseminated intravascular coagulation or massive hemorrhage. Our data showed that infectious complications were not associated with post-operative platelet depletion (on multivariate analysis), and none of our patients showed sepsis during the early post-operative period (data not shown). Our data do not rule out the possibility that post-operative platelet depletion is associated with intra-operative hemorrhage.

A few limitations to this study must be considered when interpreting our findings. One problem was the limited number of patients with anastomotic insufficiency (n = 13), which rules out identification of strong correlations with any risk factor. A multi-institutional database would allow further discussion of the risk factors for anastomotic insufficiency after hepatic resection for cholangiocarcinoma. However, the present findings represent a first step toward such a multi-institutional study to clarify the risk factors for anastomotic insufficiency following intrahepatic cholangiojejunostomy.

Another problem was that our present study was limited by its retrospective design. We also cannot fully exclude the possibility that patients with a low platelet count on POD1 were simply in a worse general condition, and therefore showed delayed recovery of liver regeneration or a greater incidence of anastomotic insufficiency than patients with normal platelet counts. However, we could not identify any significant differences between patients with and without pre-operative platelet depletion in terms of pre-operative liver function (PT-INR or ICGR-15). The reasons for the association between pre-operative platelet depletion and anastomotic insufficiency following intrahepatic cholangiojejunostomy thus remain unclear. The point clearly identified by our data was that pre-operative platelet depletion and intra-operative massive hemorrhage were both closely associated with post-operative platelet depletion, and post-operative platelet depletion was a significant cause of anastomotic insufficiency following intrahepatic cholangiojejunostomy.

If platelet depletion was a significant cause of anastomotic insufficiency following intrahepatic cholangiojejunostomy, one potential strategy could be to deliberately increase the platelet count during the early post-operative period. However, the current findings should not be seen as a recommendation for more liberal use of platelet concentrates from blood donors, as several studies have shown that platelet transfusion is associated with increased risks of post-operative morbidity and mortality [3032]. In contrast to endogenous platelets, platelets from blood donors are frequently in an activated state and may induce a range of inflammatory reactions and unwanted side effects [33, 34]. New strategies for increasing platelet count safely or for the use of growth factors associated with wound healing and liver regeneration are thus needed. One possible strategy is the use of PRP to decrease anastomotic insufficiency. However, before clinical applications can be seriously contemplated, further investigation is needed to clarify whether PRP is useful for reducing the incidence of anastomotic insufficiency following intrahepatic cholangiojejunostomy. Given our findings and the results from Nagino et al., minimizing intra-operative hemorrhage is important [9].

Conclusion

The incidence of anastomotic insufficiency following intrahepatic cholangiojejunostomy was 6% in this single, high-volume center experience.

Post-operative platelet depletion (to <10 × 104/μL on POD1) was associated with anastomotic insufficiency following intrahepatic cholangiojejunostomy, but further experimental and clinical studies are needed to elucidate the underlying mechanisms and clarify correlations between platelet count and intrahepatic cholangiojejunostomy.

Declarations

Acknowledgement

The authors wish to thank all the members of Gastroenterological Surgery II, Hokkaido University Hospital for their clinical assistance.

Authors’ Affiliations

(1)
Department of Gastroenterological Surgery II, Graduate School of Medicine, Hokkaido University

References

  1. Hasegawa S, Ikai I, Fujii H, Hatano E, Shimahara Y: Surgical resection of hilar cholangiocarcinoma: analysis of survival and postoperative complications. World J Surg. 2007, 31 (6): 1256-1263.View ArticlePubMedGoogle Scholar
  2. Matsuo K, Rocha FG, Ito K, D’Angelica MI, Allen PJ, Fong Y, Dematteo RP, Gonen M, Endo I, Jarnagin WR: The Blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of resectability and outcomes in 380 patients. J Am Coll Surg. 2012, 215 (3): 343-355. 10.1016/j.jamcollsurg.2012.05.025.View ArticlePubMedGoogle Scholar
  3. Igami T, Nishio H, Ebata T, Yokoyama Y, Sugawara G, Nimura Y, Nagino M: Surgical treatment of hilar cholangiocarcinoma in the “new era”: the Nagoya University experience. J Hepatobiliary Pancreat Sci. 2010, 17 (4): 449-454. 10.1007/s00534-009-0209-0.View ArticlePubMedGoogle Scholar
  4. Otani K, Chijiiwa K, Kai M, Ohuchida J, Nagano M, Tsuchiya K, Kondo K: Outcome of surgical treatment of hilar cholangiocarcinoma. J Gastrointest Surg. 2008, 12 (6): 1033-1040. 10.1007/s11605-007-0453-z.View ArticlePubMedGoogle Scholar
  5. Silva MA, Tekin K, Aytekin F, Bramhall SR, Buckels JA, Mirza DF: Surgery for hilar cholangiocarcinoma; a 10 year experience of a tertiary referral centre in the UK. Eur J Surg Oncol. 2005, 31 (5): 533-539. 10.1016/j.ejso.2005.02.021.View ArticlePubMedGoogle Scholar
  6. Ohtsuka M, Ito H, Kimura F, Shimizu H, Togawa A, Yoshidome H, Shimamura F, Shimizu Y, Miyazaki M: Extended hepatic resection and outcomes in intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg. 2003, 10 (4): 259-264. 10.1007/s00534-002-0724-8.View ArticlePubMedGoogle Scholar
  7. Hirano S, Kondo S, Tanaka E, Shichinohe T, Tsuchikawa T, Kato K, Matsumoto J, Kawasaki R: Outcome of surgical treatment of hilar cholangiocarcinoma: a special reference to postoperative morbidity and mortality. J Hepatobiliary Pancreat Sci. 2010, 17 (4): 455-462. 10.1007/s00534-009-0208-1.View ArticlePubMedGoogle Scholar
  8. Antolovic D, Koch M, Galindo L, Wolff S, Music E, Kienle P, Schemmer P, Friess H, Schmidt J, Buchler MW, Weitz J: Hepaticojejunostomy–analysis of risk factors for postoperative bile leaks and surgical complications. J Gastrointest Surg. 2007, 11 (5): 555-561. 10.1007/s11605-007-0166-3.View ArticlePubMedGoogle Scholar
  9. Nagino M, Nishio H, Ebata T, Yokoyama Y, Igami T, Nimura Y: Intrahepatic cholangiojejunostomy following hepatobiliary resection. Br J Surg. 2007, 94 (1): 70-77. 10.1002/bjs.5531.View ArticlePubMedGoogle Scholar
  10. Miyazaki M, Ito H, Nakagawa K, Ambiru S, Shimizu H, Shimizu Y, Kato A, Nakamura S, Omoto H, Nakajima N, Kimura F, Suwa T: Aggressive surgical approaches to hilar cholangiocarcinoma: hepatic or local resection?. Surgery. 1998, 123 (2): 131-136. 10.1016/S0039-6060(98)70249-1.View ArticlePubMedGoogle Scholar
  11. Ferrero A, Russolillo N, Vigano L, Sgotto E, Lo Tesoriere R, Amisano M, Capussotti L: Safety of conservative management of bile leakage after hepatectomy with biliary reconstruction. J Gastrointest Surg. 2008, 12 (12): 2204-2211. 10.1007/s11605-008-0586-8.View ArticlePubMedGoogle Scholar
  12. de Castro SM, Kuhlmann KF, Busch OR, van Delden OM, Lameris JS, van Gulik TM, Obertop H, Gouma DJ: Incidence and management of biliary leakage after hepaticojejunostomy. J Gastrointest Surg. 2005, 9 (8): 1163-1171. 10.1016/j.gassur.2005.08.010. discussion 1171–1163View ArticlePubMedGoogle Scholar
  13. Murata S, Hashimoto I, Nakano Y, Myronovych A, Watanabe M, Ohkohchi N: Single administration of thrombopoietin prevents progression of liver fibrosis and promotes liver regeneration after partial hepatectomy in cirrhotic rats. Ann Surg. 2008, 248 (5): 821-828. 10.1097/SLA.0b013e31818584c7.View ArticlePubMedGoogle Scholar
  14. Murata S, Matsuo R, Ikeda O, Myronovych A, Watanabe M, Hisakura K, Nakano Y, Hashimoto I, Ohkohchi N: Platelets promote liver regeneration under conditions of Kupffer cell depletion after hepatectomy in mice. World J Surg. 2008, 32 (6): 1088-1096. 10.1007/s00268-008-9493-0.View ArticlePubMedGoogle Scholar
  15. Tomikawa M, Hashizume M, Highashi H, Ohta M, Sugimachi K: The role of the spleen, platelets, and plasma hepatocyte growth factor activity on hepatic regeneration in rats. J Am Coll Surg. 1996, 182 (1): 12-16.PubMedGoogle Scholar
  16. Lesurtel M, Graf R, Aleil B, Walther DJ, Tian Y, Jochum W, Gachet C, Bader M, Clavien PA: Platelet-derived serotonin mediates liver regeneration. Science. 2006, 312 (5770): 104-107. 10.1126/science.1123842.View ArticlePubMedGoogle Scholar
  17. Alkozai EM, Nijsten MW, de Jong KP, de Boer MT, Peeters PM, Slooff MJ, Porte RJ, Lisman T: Immediate postoperative low platelet count is associated with delayed liver function recovery after partial liver resection. Ann Surg. 2010, 251 (2): 300-306. 10.1097/SLA.0b013e3181b76557.View ArticlePubMedGoogle Scholar
  18. Taketomi A, Kitagawa D, Itoh S, Harimoto N, Yamashita Y, Gion T, Shirabe K, Shimada M, Maehara Y: Trends in morbidity and mortality after hepatic resection for hepatocellular carcinoma: an institute’s experience with 625 patients. J Am Coll Surg. 2007, 204 (4): 580-587. 10.1016/j.jamcollsurg.2007.01.035.View ArticlePubMedGoogle Scholar
  19. Poon RT, Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, Yeung C, Wong J: Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg. 2004, 240 (4): 698-708. discussion 708–610PubMedPubMed CentralGoogle Scholar
  20. Clavien PA, Petrowsky H, DeOliveira ML, Graf R: Strategies for safer liver surgery and partial liver transplantation. N Engl J Med. 2007, 356 (15): 1545-1559. 10.1056/NEJMra065156.View ArticlePubMedGoogle Scholar
  21. Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT: Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost. 2004, 91 (1): 4-15.PubMedGoogle Scholar
  22. Rozman P, Bolta Z: Use of platelet growth factors in treating wounds and soft-tissue injuries. Acta Dermatovenerol Alp Panonica Adriat. 2007, 16 (4): 156-165.Google Scholar
  23. Hasegawa Y, Abo D, Sakuhara Y, Kato F, Kamishimma T, Shimizu T, Ito YM, Terae S, Shirato H: Usefulness of portography and contrast-enhanced computed tomography to predict the embolized area in percutaneous transhepatic portal vein embolization with absolute ethanol under temporary balloon occlusion. Jpn J Radiol. 2012, 30 (1): 53-61. 10.1007/s11604-011-0008-9.View ArticlePubMedGoogle Scholar
  24. Ttcot IHPBA: The Brisbane 2000 terminology of hepatic anatomy and resections. HPB Surgery. 2000, 2: 333-339.Google Scholar
  25. Hirano S, Tanaka E, Tsuchikawa T, Matsumoto J, Shichinohe T, Kato K: Techniques of biliary reconstruction following bile duct resection (with video). J Hepatobiliary Pancreat Sci. 2012, 19 (3): 203-209. 10.1007/s00534-011-0475-5.View ArticlePubMedGoogle Scholar
  26. Dindo D, Demartines N, Clavien PA: Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004, 240 (2): 205-213. 10.1097/01.sla.0000133083.54934.ae.View ArticlePubMedPubMed CentralGoogle Scholar
  27. Rahbari NN, Garden OJ, Padbury R, Brooke-Smith M, Crawford M, Adam R, Koch M, Makuuchi M, Dematteo RP, Christophi C, Banting S, Usatoff V, Nagino M, Maddern G, Hugh TJ, Vauthey JN, Greig P, Rees M, Yokoyama Y, Fan ST, Nimura Y, Figueras J, Capussotti L, Büchler MW, Weitz J: Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011, 149 (5): 713-724. 10.1016/j.surg.2010.10.001.View ArticlePubMedGoogle Scholar
  28. Yol S, Tekin A, Yilmaz H, Kucukkartallar T, Esen H, Caglayan O, Tatkan Y: Effects of platelet rich plasma on colonic anastomosis. J Surg Res. 2008, 146 (2): 190-194. 10.1016/j.jss.2007.05.015.View ArticlePubMedGoogle Scholar
  29. Gomez-Caro A, Ausin P, Boada M: Platelet rich plasma improves the healing process after airway anastomosis. Interact Cardiovasc Thorac Surg. 2011, 13 (6): 552-556. 10.1510/icvts.2011.273995.View ArticlePubMedGoogle Scholar
  30. de Boer MT, Christensen MC, Asmussen M, van der Hilst CS, Hendriks HG, Slooff MJ, Porte RJ: The impact of intraoperative transfusion of platelets and red blood cells on survival after liver transplantation. Anesth Analg. 2008, 106 (1): 32-44. 10.1213/01.ane.0000289638.26666.ed. table of contentsView ArticlePubMedGoogle Scholar
  31. Spiess BD: Transfusion of blood products affects outcome in cardiac surgery. Semin Cardiothorac Vasc Anesth. 2004, 8 (4): 267-281. 10.1177/108925320400800402.View ArticlePubMedGoogle Scholar
  32. Pereboom IT, Lisman T, Porte RJ: Platelets in liver transplantation: friend or foe?. Liver Transpl. 2008, 14 (7): 923-931. 10.1002/lt.21510.View ArticlePubMedGoogle Scholar
  33. Cognasse F, Boussoulade F, Chavarin P, Acquart S, Fabrigli P, Lamy B, Garraud O: Release of potential immunomodulatory factors during platelet storage. Transfusion. 2006, 46 (7): 1184-1189. 10.1111/j.1537-2995.2006.00869.x.View ArticlePubMedGoogle Scholar
  34. Khan SY, Kelher MR, Heal JM, Blumberg N, Boshkov LK, Phipps R, Gettings KF, McLaughlin NJ, Silliman CC: Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood. 2006, 108 (7): 2455-2462. 10.1182/blood-2006-04-017251.View ArticlePubMedPubMed CentralGoogle Scholar
  35. Pre-publication history

    1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2482/14/81/prepub

Copyright

© Noji et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement